JJ PHARMA CONSULT ApS: Financial statements 2013
CVR: 33257635
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -8,909 and a net result of DKK 94,586 compared with DKK 22,154 the year before. Equity in the 2013 report amounted to DKK 183,451. The solvency ratio was 32.3%.
- Gross Profit
- DKK -8,909
- Profit/Loss
- DKK 94,586
- Equity
- DKK 183,451
- Total Assets
- DKK 567,749
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -9 t. | 95 t. | 183 t. | - |
| 2012 | - | -6 t. | 22 t. | 89 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
JJ PHARMA CONSULT ApS has published its annual report for 2012. Gross profit came to DKK -6,438, and the net result was DKK 22,154.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.